Effect of preoperative oral antibiotics in combination with mechanical bowel preparation on inflammatory response and short-term outcomes following left-sided colonic and rectal resections.

Background: Preoperative oral antibiotics in addition to intravenous antibiotics and mechanical bowel preparation (MBP) may influence the gut microbiome and reduce both the postoperative systemic inflammatory response to surgery and postoperative infective complications following colorectal resection. This propensity score-matched study compared outcomes of patients undergoing left-sided colonic or rectal resection with or without a combination of oral antibiotics and MBP.
Methods: The addition of oral antibiotics and MBP to prophylactic intravenous antibiotics in left-sided colonic and rectal resections was introduced in 2015-2016 at a single institution. Propensity score matching was undertaken to compare the effects of oral antibiotics plus MBP versus neither oral antibiotics nor MBP on the postoperative systemic inflammatory response and short-term outcomes in patients undergoing left-sided colonic or rectal resection between 2013 and 2018.
Results: Of 396 patients who had propensity score matching for host, anaesthetic and operative factors, 204 matched patients were identified. The addition of oral antibiotics and MBP was associated with a significantly reduced postoperative inflammatory response (reduced postoperative Glasgow Prognostic Score) on day 3 (odds ratio (OR) 0·66, 95 per cent c.i. 0·44 to 0·99; P = 0·013) and day 4 (OR 0·46, 0·30 to 0·71; P = 0·001). Significantly reduced overall complications (OR 0·31, 0·17 to 0·56; P < 0·001), infective complications (OR 0·41, 0·22 to 0·77; P = 0·011), surgical-site infection (OR 0·37, 0·17 to 0·83; P = 0·024) and postoperative length of hospital stay (median 7 days versus 8 days in patients who had intravenous antibiotics alone; P = 0·050) were also observed.
Conclusion: Preoperative oral antibiotics and MBP in addition to prophylactic intravenous antibiotics were associated with a reduction in the postoperative systemic inflammatory response and postoperative complications in patients undergoing resectional left-sided colonic or rectal surgery.

Introduction

Approximately 1·8 million patients are diagnosed with colorectal cancer worldwide each year1. Resectional surgery remains the mainstay of treatment, albeit with significant morbidity as well as cancer‐related mortality, even after curative treatment2.

A previous Cochrane review3 reported clear evidence for antibiotic prophylaxis versus no antibiotic prophylaxis in the reduction of surgical‐site infection (SSI) following colorectal surgery. In that review, evidence comparing either oral or intravenous antibiotic administration was limited, although no significant difference was found. When a combination of intravenous and oral antibiotic therapy was compared with single‐route administration, a significant reduction in wound infection was reported (risk ratio 0·55, P < 0·001). Most studies have compared the effects of oral antibiotic administration in the context of mechanical bowel preparation (MBP). The effect of oral antibiotics in addition to intravenous antibiotics in the unprepared colon is uncertain. This is reflected in the WHO SSI prevention guidelines4 and a recent update to the Enhanced Recovery After Surgery (ERAS®) Society guidelines5, both of which support the use of intravenous antibiotic prophylaxis immediately before surgery in addition to oral antibiotics when MBP is being used, but acknowledge the need for further research into the role of oral antibiotics without MBP.

After colorectal resection there are significant relationships between increased postoperative systemic inflammatory response and more postoperative morbidity6, 7, 8, as well as poorer long‐term oncological outcomes9, 10, 11. Measures that modulate the systemic inflammatory response after surgery and reduce postoperative complications are therefore of clinical interest.

The administration of prophylactic intravenous antibiotics on induction of anaesthesia is now routine, whereas the use of preoperative oral antibiotics remains limited, as reported in a recent European survey12 and international audit13. Evidence, largely from the USA and Japan, has been summarized by several meta‐analyses14, 15, 16, 17 reporting a reduction in postoperative infective complications following the use of oral in addition to intravenous antibiotics. It has been hypothesized18, 19 that a local alteration in the gut microbiome could have a significant relationship with the host systemic inflammatory response, modifying the risk of complications.

The primary aim of this propensity‐matched study was to examine the impact of preoperative oral antibiotics in combination with MBP, given in addition to intravenous antibiotics, on postoperative infective complications in patients undergoing left‐sided colonic or rectal resection. As a secondary aim, the impact of preoperative oral antibiotics on the postoperative systemic inflammatory response was examined.

Methods

This longitudinal observational study included patients aged at least 18 years undergoing elective left‐sided colonic or rectal resection at Glasgow Royal Infirmary between 2013 and 2018. Surgery was undertaken for either benign disease or colorectal cancer resection with curative intent. Patients with coexisting inflammatory bowel disease or metastatic disease, those undergoing multivisceral resections, and those undergoing emergency surgery were excluded. All operations were performed or supervised by a consultant colorectal surgeon.

During the time period for inclusion into this study, an ERAS pathway was in place to standardize perioperative care. This included: preoperative carbohydrate‐loading where appropriate; prophylactic intravenous antibiotics at induction of anaesthesia; venous thromboprophylaxis; early enteral nutrition; early mobilization; and avoidance of routine peritoneal or nasogastric drainage. The use of perioperative dexamethasone to reduce the risk of postoperative nausea and vomiting, and regional anaesthetic technique was at the discretion of the surgical and anaesthetic teams caring for the patient.

Preoperative oral antibiotics and MBP were introduced in 2015, but their use was not widespread until 2016. Before 2015–2016, and therefore in the control group, neither oral antibiotics nor MBP were in routine use. Instead, patients undergoing rectal surgery were given a single phosphate enema, whereas those having a left‐sided colonic resection received no bowel preparation. Patients in the treatment group were treated predominantly in 2016–2018, and received preoperative oral antibiotics in the form of neomycin (1 g) and metronidazole (400 mg) at 15·00, 16·00 and 22·00 hours on the day before surgery, and oral MBP in the form of four sachets of Klean‐Prep® (Norgine, Harefield, UK), a macrogol‐based laxative. All patients received prophylactic intravenous antibiotics on induction of anaesthesia regardless of whether they were in the control group, predominantly from 2013 to 2016, or the treatment group, predominantly from 2016 to 2018.

Patients were assessed clinically every day after surgery with blood analysis, including estimation of C‐reactive protein (CRP) on most postoperative days. Other investigations and interventions for clinical or biochemical concerns were carried out at the discretion of the team caring for the patient.

Clinicopathological data were collected in a secure, prospectively collated, electronic database in line with local NHS Greater Glasgow and Clyde policy, which detailed whether or not patients received oral antibiotics and MBP. Additional data, including laboratory results, clinical letters, inpatient records and operation notes, were obtained from online patient records.

Clinicopathological data collected included: site of surgery (left‐sided, rectal without perineal incision, rectal with perineal incision); presence of diabetes; use of perioperative dexamethasone; use of regional anaesthesia; surgical approach (laparoscopic or open); duration of surgery; need for intraoperative blood transfusion; and the preoperative inflammatory state using the modified Glasgow Prognostic Score (mGPS)20.

Outcomes of interest were postoperative complications, the postoperative inflammatory response, and postoperative length of hospital stay.

Complications were categorized as overall complications, infective complications and non‐infective complications. Infective complications were subcategorized as non‐SSI or SSIs, which were then further subcategorized as follows: superficial SSI (presence of pus either discharging spontaneously or requiring drainage or the use of antibiotics due to a diagnosis of cellulitis around the wound); deep SSI (intra‐abdominal pus or infection requiring either drainage or antibiotic therapy); or anastomotic leakage (diagnosed either on imaging or at laparotomy). Complications were categorized by severity using the Clavien–Dindo classification21.

A CRP threshold above 150 mg/l and an albumin level below 25 mg/l on day 3 and 4 was recorded. A postoperative Glasgow Prognostic Score (poGPS)8 was calculated for patients for whom CRP and albumin results were available. Postoperative mortality was defined as death within 30 days of surgery. Length of hospital stay was defined as the median number of days between surgery and hospital discharge.

This study was approved by NHS Greater Glasgow and Clyde Information Governance Unit and the Caldicott Guardian as part of surgical audit. Data were collected by clinical research fellows, with discussion with a senior author when appropriate. Those collecting data had access to the database and online patient records.

Statistical analysis

In the unmatched cohort, categorical data were compared using the χ2 test. Data on postoperative length of stay were non‐parametric and are presented as median (range) values. Medians were compared using an independent‐samples median test. A two‐sided P < 0·050 was considered significant. Measurement of association between variables for both unmatched and matched data was carried out using either the φ coefficient or Cramer's V test (φc). All statistical analyses were carried out using IBM SPSS® version 24 for Windows® (IBM, Armonk, New York, USA).

Patients were propensity score matched for age, sex, site of surgery, surgical approach, BMI, ASA grade, smoking status, preoperative mGPS, intraoperative blood transfusion, stoma formation, coexisting diabetes, use of regional anaesthesia, and use of preoperative dexamethasone. Each patient who received preoperative oral antibiotics was matched 1 : 1 with a patient who did not, using the closest propensity score on the logit scale (calliper less than 0·05, order of match selection randomized, without replacement). The appropriateness of propensity score matching was assessed visually by the frequency of propensity scores in each group before and after matching. Propensity scores were calculated only for patients who did not have missing data in the variables used in the propensity scoring process.

Within the propensity score‐matched data, McNemar's test was used to compare categorical data when this was in a 2 × 2 table or using a McNemar–Bowker test22 when the data table was more than 2 × 2. Binary logistic regression was used to calculate odds ratios (ORs) and 95 per cent c.i. for outcomes within the propensity score‐matched data set.

The treatment effect of preoperative oral antibiotics and MBP in terms of poGPS on day 3 after surgery, overall complications and overall infective complications was displayed as ORs with 95 per cent c.i. for unmatched and matched patients. In addition, propensity scores were included along with preoperative oral antibiotics and MBP as a linear co‐variable in multivariable binary logistic regression for day 3 poGPS, overall complications and infective complications.

Results

A total of 396 patients were included in this study, of whom 227 (57·3 per cent) did not and 169 (42·7 per cent) did receive preoperative oral antibiotics (Fig. 1). Some 223 patients (56·3 per cent) were men, and 131 (33·1 per cent) were aged over 65 years. Most had rectal (266 patients, 67·2 per cent) and malignant (90·6 per cent) disease. Laparoscopic resections were carried out in 192 patients (48·5 per cent), with the remainder having open surgery.

Figure 1

Flow diagram of antibiotic administration before and after propensity score matching MBP, mechanical bowel preparation.

Patient characteristics for the entire cohort are shown in Table  1. There were significant differences between the group of patients who received preoperative oral antibiotics and MBP and those who did not for age (φc = 0·124, P = 0·048), site of surgery (φc = 0·199, P < 0·001), proportion of malignant disease (φ = −0·372, P < 0·001), ASA grade (φc = 0·217, P < 0·001), smoking history (φc = 0·141, P = 0·020), preoperative mGPS (φc = 0·131, P = 0·043), need for intraoperative blood transfusion (φ = −0·135, P = 0·008), proportion of patients with a stoma (φ = −0·132, P = 0·009) and the use of regional anaesthesia (φc = 0·391, P < 0·001) or dexamethasone (φ = 0·109, P = 0·033).

Table 1

Association between clinicopathological characteristics, perioperative factors and oral antibiotic administration in patients undergoing left‐sided colonic or rectal surgery, before propensity score matching

	Total (n = 396)	No oral antibiotics (n = 227)	Oral antibiotics (n = 169)	φ/Cramer's V	P *
Age (years)				0·124	0·048
< 65	183 (46·2)	93 (41·0)	90 (53·3)
65–74	131 (33·1)	84 (37·0)	47 (27·8)
≥ 75	82 (20·7)	50 (22·0)	32 (18·9)
Sex				−0·012	0·811
M	223 (56·3)	129 (56·8)	94 (55·6)
F	173 (43·7)	98 (43·2)	75 (44·4)
Site of surgery				0·199	< 0·001
Left colon	130 (32·8)	65 (28·6)	65 (38·5)
Rectal (without perineal incision)	219 (55·3)	123 (54·2)	96 (56·8)
Rectal (with perineal incision)	47 (11·9)	39 (17·2)	8 (4·7)
Benign or malignant	n = 395	n = 226		−0·372	< 0·001
Benign	37 (9·4)	0 (0)	37 (21·9)
Malignant	358 (90·6)	226 (100)	132 (78·1)
Laparoscopic or open				0·082	0·101
Laparoscopic	192 (48·5)	102 (44·9)	90 (53·3)
Open	204 (51·5)	125 (55·1)	79 (46·7)
BMI (kg/m 2 )	n = 395	n = 226		0·118	0·137
< 20	13 (3·3)	8 (3·5)	5 (3·0)
20–25	137 (34·7)	86 (38·1)	51 (30·2)
26–30	137 (34·7)	80 (35·4)	57 (33·7)
> 30	108 (27·3)	52 (23·0)	56 (33·1)
ASA grade	n = 384	n = 224	n = 160	0·217	< 0·001
I	99 (25·8)	73 (32·6)	26 (16·3)
II	184 (47·9)	104 (46·4)	80 (50·0)
III	96 (25·0)	43 (19·2)	53 (33·1)
IV	5 (1·3)	4 (1·8)	1 (0·6)
Smoking status	n = 395	n = 226		0·141	0·020
Never	187 (47·3)	109 (48·2)	78 (46·2)
Ex‐smoker	140 (35·4)	88 (38·9)	52 (30·8)
Smoker	68 (17·2)	29 (12·8)	39 (23·1)
Diabetes	n = 395			0·023	0·649
No	347 (87·8)	200 (88·5)	147 (87·0)
Yes	48 (12·2)	26 (11·5)	22 (13·0)
Preoperative mGPS	n = 367	n = 216	n = 151	0·131	0·043
0	302 (82·3)	176 (81·5)	126 (83·4)
1	29 (7·9)	13 (6·0)	16 (10·6)
2	36 (9·8)	27 (12·5)	9 (6·0)
Intraoperative transfusion	n = 385	n = 217	n = 168	−0·135	0·008
No	372 (96·6)	205 (94·5)	167 (99·4)
Yes	13 (3·4)	12 (5·5)	1 (0·6)
Stoma				−0·132	0·009
No	204 (51·5)	104 (45·8)	100 (59·2)
Yes	192 (48·5)	123 (54·2)	69 (40·8)
Duration of surgery > 4 h	n = 391	n = 225	n = 166	0·077	0·128
No	132 (33·8)	83 (36·9)	49 (29·5)
Yes	259 (66·2)	142 (63·1)	117 (70·5)
Other anaesthesia	n = 377	n = 211	n = 166	0·391	< 0·001
None	85 (22·5)	47 (22·3)	38 (22·9)
Spinal	144 (38·2)	49 (23·2)	95 (57·2)
Epidural	98 (26·0)	79 (37·4)	19 (11·4)
Other	50 (13·3)	36 (17·1)	14 (8·4)
Dexamethasone	n = 382	n = 215	n = 167	0·109	0·033
No	96 (25·1)	63 (29·3)	33 (19·8)
Yes	286 (74·9)	152 (70·7)	134 (80·2)

Values in parentheses are percentages. mGPS, modified Glasgow Prognostic Score.

χ2 test.

Propensity score‐matched patients

It was not possible to assign propensity scores to 153 patients because of missing co‐variable data; thus, propensity scores were assigned to 243 patients, 102 of whom did not and 141 of whom did receive preoperative oral antibiotics. Overall, 204 patients (102 from each group) were matched based on their propensity score (Fig. 1). There was subsequent improvement in the balance of the distribution of propensity scores in each group on visual representation (Fig. 2), and improvement in the φ coefficient/Cramer's φ (φc), as shown in Table  2.

Figure 2

Distribution of propensity scores before and after matching

Table 2

Association between clinicopathological characteristics, perioperative factors and oral antibiotic administration in patients undergoing left‐sided colonic or rectal surgery, after propensity score matching

	Variable matched for	Total (n = 204)	No oral antibiotics (n = 102)	Oral antibiotics (n = 102)	φ/Cramer's V
Age (years)	Yes				0·114
< 65		91 (44·6)	44 (43·1)	47 (46·1)
65–74		70 (34·3)	40 (39·2)	30 (29·4)
≥ 75		43 (21·1)	18 (17·6)	25 (24·5)
Sex	Yes				−0·010
M		115 (56·4)	58 (56·9)	57 (55·9)
F		89 (43·6)	44 (43·1)	45 (44·1)
Site of surgery	Yes				0·119
Left colon		64 (31·4)	34 (33·3)	30 (29·4)
Rectal (without perineal incision)		120 (58·8)	55 (53·9)	65 (63·7)
Rectal (with perineal incision)		20 (9·8)	13 (12·7)	7 (6·9)
Benign or malignant	No				0·271
Benign		14 (6·9)	0 (0)	14 (13·7)
Malignant		190 (93·1)	102 (100)	88 (86·3)
Laparoscopic or open	Yes				0·010
Laparoscopic		111 (54·4)	55 (53·9)	56 (54·9)
Open		93 (45·6)	47 (46·1)	46 (45·1)
BMI (kg/m 2 )	Yes				0·038
< 20		4 (2·0)	2 (2·0)	2 (2·0)
20–25		73 (35·8)	38 (37·3)	35 (34·3)
26–30		72 (35·3)	36 (35·3)	36 (35·3)
> 30		55 (27·0)	26 (25·5)	29 (28·4)
ASA grade	Yes				0·077
I		47 (23·0)	25 (24·5)	22 (21·6)
II		98 (48·0)	50 (49·0)	48 (47·1)
III		56 (27·5)	25 (24·5)	31 (30·4)
IV		3 (1·5)	2 (2·0)	1 (1·0)
Smoking status	Yes				0·144
Never		91 (44·6)	43 (42·2)	48 (47·1)
Ex‐smoker		75 (36·8)	44 (43·1)	31 (30·4)
Smoker		38 (18·6)	15 (14·7)	23 (22·5)
Diabetes	Yes				0·032
No		182 (89·2)	92 (90·2)	90 (88·2)
Yes		22 (10·8)	10 (9·8)	12 (11·8)
Preoperative mGPS	Yes				0·018
0		175 (85·8)	88 (86·3)	87 (85·3)
1		17 (8·3)	8 (7·8)	9 (8·8)
2		12 (5·9)	6 (5·9)	6 (5·9)
Intraoperative transfusion	Yes				0·000
No		202 (99·0)	101 (99·0)	101 (99·0)
Yes		2 (1·0)	1 (1·0)	1 (1·0)
Duration of surgery > 4 h	Yes				0·021
No		62 (30·4)	30 (29·4)	32 (31·4)
Yes		142 (69·6)	72 (70·6)	70 (68·6)
Stoma	Yes				0·020
No		112 (54·9)	57 (55·9)	55 (53·9)
Yes		92 (45·1)	45 (44·1)	47 (46·1)
Other anaesthesia	Yes				0·300
None		60 (29·4)	39 (38·2)	21 (20·6)
Spinal		86 (42·2)	28 (27·5)	58 (56·9)
Epidural		35 (17·2)	21 (20·6)	14 (13·7)
Other		23 (11·3)	14 (13·7)	9 (8·8)
Dexamethasone	Yes				−0·038
No		37 (18·1)	17 (16·7)	20 (19·6)
Yes		167 (81·9)	85 (83·3)	82 (80·4)

Values in parentheses are percentages. mGPS, modified Glasgow Prognostic Score.

In the matched cohort, a significantly smaller proportion of patients who received oral antibiotics had a CRP level of 150 mg/l or above on postoperative day (POD) 4 (17 per cent versus 40 per cent in those who did not; P < 0·001), but not on POD 3 (35 versus 42 per cent respectively; P = 0·154) (Table  3). Significantly more patients receiving oral antibiotics had a postoperative albumin concentration of 25 mg/l or more on POD 3 (84 versus 67 per cent respectively; P = 0·003) and POD 4 (78 versus 56 per cent; P = 0·011) compared with those who did not. Correspondingly, significantly fewer patients receiving oral antibiotics had a poGPS greater than 0 on POD 3 (34 versus 43 per cent; P = 0·013) and POD 4 (17 versus 40 per cent; P = 0·001). Corresponding ORs are shown in Table  3.

Table 3

Patient outcomes within the propensity score‐matched cohort

	Total (n = 204)	No oral antibiotics + MBP (n = 102)	Oral antibiotics + MBP (n = 102)	Odds ratio†	P
CRP ≥ 150 (mg/l) (POD 3)	n = 193	n = 95	n = 98	0·73 (0·41, 1·31)	0·154
No	119 (61·7)	55 (58)	64 (65)
Yes	74 (38·3)	40 (42)	34 (35)
CRP ≥ 150 (mg/l) (POD 4)	n = 166	n = 78	n = 88	0·31 (0·15, 0·64)	< 0·001
No	120 (72·3)	47 (60)	73 (83)
Yes	46 (27·7)	31 (40)	15 (17)
Albumin ≥ 25 (mg/l) (POD 3)	n = 190	n = 94	n = 96	2·66 (1·32, 5·35)	0·003
No	46 (24·2)	31 (33)	15 (16)
Yes	144 (75·8)	63 (67)	81 (84)
Albumin ≥ 25 (mg/l) (POD 4)	n = 167	n = 78	n = 89	2·67 (1·37, 5·21)	0·011
No	54 (32·3)	34 (44)	20 (22)
Yes	113 (67·7)	44 (56)	69 (78)
poGPS (POD 3)	n = 190	n = 94	n = 96	0·66 (0·44, 0·99)	0·013
0	117 (61·6)	54 (57)	63 (66)
1	47 (24·7)	21 (22)	26 (27)
2	26 (13·7)	19 (20)	7 (7)
poGPS (POD 4)	n = 166	n = 78	n = 88	0·46 (0·30, 0·71)	0·001
0	120 (72·3)	47 (60)	73 (83)
1	16 (9·6)	8 (10)	8 (9)
2	30 (18·1)	23 (29)	7 (8)
Any complication				0·31 (0·17, 0·56)	< 0·001
No	120 (58·8)	46 (45·1)	74 (72·5)
Yes	84 (41·2)	56 (54·9)	28 (27·5)
Infective complication				0·41 (0·22, 0·77)	0·011
No	146 (71·6)	64 (62·7)	82 (80·4)
Yes	58 (28·4)	38 (37·3)	20 (19·6)
SSI				0·37 (0·17, 0·83)	0·024
No	171 (83,8)	79 (77·5)	92 (90·2)
Yes	33 (16·2)	23 (22·5)	10 (9·8)
Deep SSI				0·41 (0·10, 1·64)	0·344
No	194 (95·1)	95 (93·1)	99 (97·1)
Yes	10 (4·9)	7 (6·9)	3 (2·9)
Superficial SSI				0·25 (0·07, 0·93)	0·057
No	190 (93·1)	91 (89·2)	99 (97·1)
Yes	14 (6·9)	11 (10·8)	3 (2·9)
Anastomotic leak				0·48 (0·14, 1·65)	0·388
No	192 (94·1)	94 (92·2)	98 (96·1)
Yes	12 (5·9)	8 (7·8)	4 (3·9)
Non‐SSI infection				0·63 (0·27, 1·48)	0·405
No	179 (87·7)	87 (85·3)	92 (90·2)
Yes	25 (12·3)	15 (14·7)	10 (9·8)
Clavien–Dindo complication grade				0·51 (0·33, 0·80)	0·007
0	123 (60·3)	49 (48·0)	74 (72·5)
I–II	61 (29·9)	41 (40·2)	20 (19·6)
III–V	20 (9·8)	12 (11·8)	8 (7·8)
Postoperative death				–
No	201 (98·5)	99 (97·1)	102 (100)
Yes	3 (1·5)	3 (2·9)	0 (0)
Postoperative length of stay (days) *		8 (2–122)	7 (2–69)	–	0·050

Values in parentheses are percentages unless indicated otherwise;

values are median (range);

values in parentheses are 95 per cent confidence intervals. MBP, mechanical bowel preparation; POD, postoperative day; poGPS, postoperative Glasgow Prognostic Score; SSI, surgical‐site infection.

A significant reduction in overall complications was observed in the group receiving preoperative oral antibiotics (27·5 per cent versus 55·9 per cent in patients not receiving oral antibiotics; P < 0·001). Preoperative oral antibiotics were associated with a significant reduction in the rate of infective complications (19·6 versus 37·3 per cent respectively; P = 0·011) and overall SSI (9·8 versus 22·5 per cent; P = 0·024). A significant reduction was seen in overall Clavien–Dindo complication grade (P = 0·007) and postoperative length of stay (7 versus 8 days; P = 0·050) in those receiving preoperative oral antibiotics. No significant difference was seen with the use of preoperative oral antibiotics and MBP in the rate of deep SSI (2·9 versus 6·9 per cent; P = 0·344), superficial SSI (2·9 versus 10·8 per cent; P = 0·057), anastomotic leak (3·9 versus 7·8 per cent; P = 0·388) or non‐SSI (9·8 versus 14·7 per cent; P = 0·405). Corresponding ORs are shown in Table  3.

Sensitivity analysis of the impact of oral antibiotics and MBP on rates of increased poGPS on POD 3 found a similar statistically significant probability reduction using regression adjustment (OR 0·73, 95 per cent c.i. 0·50 to 1·06) and propensity score matching (OR 0·66, 0·44 to 0·99). Similar results were seen for overall complications using regression adjustment (OR 0·39, 0·23 to 0·66) and propensity score matching (OR 0·31, 0·17 to 0·56), as well as for infective complications: OR 0·48 (0·27 to 0·86) and OR 0·41 (0·22 to 0·77) respectively (Table  4).

Table 4

Odds ratios for increasing postoperative Glasgow Prognostic Score on day 3, overall and infective complications with respect to use of preoperative oral antibiotics and mechanical bowel preparation across the propensity score methods

		Odds ratio
	No. of patients	Day 3 poGPS	Overall complications	Infective complications
Propensity score model
Unadjusted	396	0·60 (0·45, 0·80)	0·50 (0·33, 0·75)	0·60 (0·39, 0·94)
PS regression	243	0·73 (0·50, 1·06)	0·39 (0·23, 0·66)	0·48 (0·27, 0·86)
Matched	204	0·66 (0·44, 0·99)	0·31 (0·17, 0·56)	0·41 (0·22, 0·77)

Values in parentheses are 95 per cent confidence intervals. poGPS, postoperative Glasgow Prognostic Score; PS, propensity score.

Discussion

The addition of preoperative oral antibiotics in combination with MBP to standard ERAS care (including prophylactic intravenous antibiotics) was associated with significantly reduced postoperative systemic inflammatory response, infective complications and length of hospital stay in patients undergoing left‐sided colonic or rectal resection. Within the matched cohort there was a reduced poGPS on POD 3 and 4, and significantly fewer overall complications, overall infective complications, overall SSIs and superficial SSIs. The addition of oral antibiotics improved patient outcomes.

This study complements existing literature supporting the beneficial effect of oral antibiotics in addition to intravenous antibiotics and MBP in reducing postoperative systemic inflammation and complications after left‐sided colonic and rectal resections. This includes a recent international multicentre audit13 reporting a reduction in anastomotic leaks with a combination of preoperative oral antibiotics and MBP, and a recent meta‐analysis15 suggesting a significant beneficial effect of addition of oral antibiotics to MBP in reducing overall morbidity and mortality, including SSI and anastomotic leak.

The level 1 evidence for preoperative oral antibiotics is limited to a number of relatively small, often historical, trials, as summarized in several recent meta‐analyses14, 15, 23. Many of these trials compared oral antibiotics with no oral antibiotics only in patients receiving MBP. Thus it was not clear whether additional beneficial effects from oral antibiotics would be seen in patients without MBP. The addition of oral antibiotics in patients receiving MBP has, however, now been incorporated into the most recent ERAS® update5.

Although not specifically analysed in the present study, the combination of oral antibiotics and MBP was both tolerable and acceptable to patients. Current literature reports minimal adverse events with this intervention. One RCT24 reported increased nausea and vomiting in patients receiving three preoperative doses of oral antibiotics compared with that in patients receiving either one dose or no antibiotics (P < 0·001), although other trials25, 26, 27, 28, 29 have reported no negative effects of additional oral antibiotics in terms of enteritis, colitis and/or diarrhoea, including Clostridium difficile infection.

A heightened postoperative systemic inflammatory response is associated with both increased postoperative complications and worse long‐term outcomes, including an increased rate of cancer recurrence, poorer survival and decreased quality of life11, 30, 31, 32. Reducing both the postoperative systemic inflammatory response and postoperative complications is important in improving both short‐ and long‐term outcomes for the patients, in addition to economic benefits.

The present study has a number of limitations. Propensity score matching to minimize selection bias resulted in the exclusion of a substantial proportion of patients initially included in the study. Although the cohort that did not receive oral antibiotics included only patients undergoing resection for malignant pathology, the group that did receive oral antibiotics and MBP additionally included a small proportion of patients who had a resection for benign pathology. The present analysis did not propensity score match for this variation. It seems unlikely that this discrepancy would have had a significant effect on short‐term outcomes. There was no statistically significant reduction in deep SSI or anastomotic leak rates, as reported in some larger studies29. It seems likely that this reflected relatively low rates of these complications that this study was not powered to detect. The longitudinal nature of the study may have introduced bias between groups owing to changes in anaesthetic/surgical technique over the time period included, but no major alterations to surgical or anaesthetic technique, other than the introduction of oral antibiotics and MBP, were apparent. Dexamethasone and regional anaesthesia use were included within propensity score matching to minimize the potential for bias due to these interventions.

The addition of preoperative antibiotics and MBP to standard perioperative care resulted in significant reduction in the postoperative systemic inflammatory response, postoperative morbidity and postoperative length of stay in patients undergoing elective left‐sided colonic or rectal resection. This strategy is worthy of further investigation and potentially wider adoption.